Birdwatch Archive

Birdwatch Note

2024-12-30 18:46:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

La vacuna Patria desarrollada entre el Gobierno de México y el laboratorio privado Avimex fue aprobada por COFEPRIS el 6 de junio de 2024 y en diciembre comenzó su aplicación a grupos vulnerables con poco más de 700mil unidades. https://www.gob.mx/cofepris/articulos/cofepris-aprueba-la-vacuna-mexicana-patria-contra-covid-19 https://24-horas.mx/mexico/vacuna-patria-ya-se-aplica-a-grupos-vulnerables-sheinbaum/

Written by 1D4B9C7F2C968BD415A5576B55628851E9DA7C4003F6DFE6EFD248C4D56685E2
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1873768714245747017

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1873802965829492992
  • noteId - 1873802965829492992
  • participantId -
  • noteAuthorParticipantId - 1D4B9C7F2C968BD415A5576B55628851E9DA7C4003F6DFE6EFD248C4D56685E2 Participant Details
  • createdAtMillis - 1735584415286
  • tweetId - 1873768714245747017
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • La vacuna Patria desarrollada entre el Gobierno de México y el laboratorio privado Avimex fue aprobada por COFEPRIS el 6 de junio de 2024 y en diciembre comenzó su aplicación a grupos vulnerables con poco más de 700mil unidades. https://www.gob.mx/cofepris/articulos/cofepris-aprueba-la-vacuna-mexicana-patria-contra-covid-19 https://24-horas.mx/mexico/vacuna-patria-ya-se-aplica-a-grupos-vulnerables-sheinbaum/

Note Ratings

rated at rated by
2024-12-31 23:35:28 -0600 Rating Details
2024-12-31 18:20:41 -0600 Rating Details
2024-12-31 10:38:34 -0600 Rating Details
2024-12-31 10:31:53 -0600 Rating Details
2024-12-31 09:32:29 -0600 Rating Details
2024-12-31 08:48:42 -0600 Rating Details
2024-12-31 05:11:17 -0600 Rating Details
2024-12-31 02:40:29 -0600 Rating Details
2024-12-30 23:15:27 -0600 Rating Details
2024-12-30 22:17:47 -0600 Rating Details
2024-12-30 19:14:26 -0600 Rating Details
2024-12-30 18:02:29 -0600 Rating Details
2024-12-30 16:03:47 -0600 Rating Details
2024-12-30 15:01:53 -0600 Rating Details
2025-01-01 08:15:06 -0600 Rating Details
2024-12-31 22:03:24 -0600 Rating Details
2024-12-31 16:04:19 -0600 Rating Details
2024-12-31 13:56:31 -0600 Rating Details
2024-12-31 13:28:32 -0600 Rating Details
2024-12-31 09:57:16 -0600 Rating Details
2024-12-30 19:39:34 -0600 Rating Details
2024-12-30 18:43:08 -0600 Rating Details
2024-12-30 17:55:26 -0600 Rating Details
2024-12-30 17:25:38 -0600 Rating Details
2024-12-30 16:02:57 -0600 Rating Details
2024-12-30 14:41:31 -0600 Rating Details
2024-12-30 14:21:52 -0600 Rating Details
2024-12-30 14:07:01 -0600 Rating Details
2024-12-30 14:02:00 -0600 Rating Details
2024-12-30 13:36:35 -0600 Rating Details
2024-12-30 13:16:00 -0600 Rating Details
2025-01-02 18:11:15 -0600 Rating Details
2025-01-01 18:59:24 -0600 Rating Details
2025-01-01 03:00:09 -0600 Rating Details
2024-12-31 23:25:26 -0600 Rating Details
2024-12-31 20:33:29 -0600 Rating Details
2024-12-31 13:59:51 -0600 Rating Details
2024-12-31 13:08:39 -0600 Rating Details
2024-12-31 10:14:53 -0600 Rating Details
2024-12-31 08:51:20 -0600 Rating Details
2024-12-31 08:31:41 -0600 Rating Details
2024-12-31 07:57:11 -0600 Rating Details
2024-12-31 06:12:57 -0600 Rating Details
2024-12-31 00:42:08 -0600 Rating Details
2024-12-30 23:03:57 -0600 Rating Details
2024-12-30 22:16:19 -0600 Rating Details
2024-12-30 21:30:31 -0600 Rating Details
2024-12-30 21:23:08 -0600 Rating Details
2024-12-30 20:30:20 -0600 Rating Details
2024-12-30 19:56:09 -0600 Rating Details
2024-12-30 18:03:57 -0600 Rating Details
2024-12-30 16:15:31 -0600 Rating Details
2024-12-30 15:34:06 -0600 Rating Details
2024-12-30 14:48:47 -0600 Rating Details
2024-12-30 14:40:30 -0600 Rating Details
2024-12-30 14:29:17 -0600 Rating Details
2024-12-30 13:57:29 -0600 Rating Details
2024-12-31 15:11:53 -0600 Rating Details
2024-12-31 14:03:54 -0600 Rating Details
2024-12-31 13:51:21 -0600 Rating Details
2024-12-31 11:01:25 -0600 Rating Details
2024-12-31 09:19:02 -0600 Rating Details
2024-12-31 08:28:59 -0600 Rating Details
2024-12-31 01:18:50 -0600 Rating Details
2024-12-30 22:42:49 -0600 Rating Details
2024-12-30 22:11:11 -0600 Rating Details
2024-12-30 21:57:20 -0600 Rating Details
2024-12-30 21:41:00 -0600 Rating Details
2024-12-30 20:55:14 -0600 Rating Details
2024-12-30 20:23:38 -0600 Rating Details
2024-12-30 19:50:22 -0600 Rating Details
2024-12-30 19:37:43 -0600 Rating Details
2024-12-30 18:03:08 -0600 Rating Details
2024-12-30 17:35:01 -0600 Rating Details
2024-12-30 16:18:50 -0600 Rating Details
2024-12-30 13:57:38 -0600 Rating Details
2024-12-31 16:36:19 -0600 Rating Details
2024-12-31 15:52:41 -0600 Rating Details
2024-12-31 11:42:24 -0600 Rating Details
2024-12-31 10:48:58 -0600 Rating Details
2024-12-31 02:20:30 -0600 Rating Details
2024-12-30 23:36:30 -0600 Rating Details
2024-12-30 22:14:33 -0600 Rating Details
2024-12-30 19:21:15 -0600 Rating Details
2024-12-30 16:32:54 -0600 Rating Details
2024-12-30 15:49:30 -0600 Rating Details
2024-12-30 15:14:33 -0600 Rating Details
2024-12-30 15:03:16 -0600 Rating Details
2024-12-30 13:15:11 -0600 Rating Details